Dr. Grier is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
44 Binney St
Room G350
Boston, MA 02115Phone+1 617-632-3971Fax+1 617-632-5710
Education & Training
- University of North Carolina HospitalsFellowship, Infectious Disease, 1980 - 1981
- University of North Carolina HospitalsResidency, Pediatrics, 1979 - 1980
- University of North Carolina HospitalsInternship, Transitional Year, 1976 - 1977
- Perelman School of Medicine at the University of PennsylvaniaClass of 1976
Certifications & Licensure
- MA State Medical License 1981 - 2019
- American Board of Pediatrics Pediatrics
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
Clinical Trials
- Doxorubicin Pharmacokinetic (PK) Study Start of enrollment: 2003 Jun 01
- Cytarabine in Treating Young Patients With Recurrent or Refractory Ewing's Sarcoma Start of enrollment: 2007 May 01
Publications & Presentations
PubMed
- 302 citationsComparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, in...Neyssa Marina, Sigbjørn Smeland, Stefan S. Bielack, Mark L. Bernstein, Gordana Jovic
The Lancet. Oncology. 2016-10-01 - 363 citationsSurvival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohortSigbjørn Smeland, Stefan S. Bielack, Jeremy Whelan, Mark L. Bernstein, Pancras C.W. Hogendoorn
European Journal of Cancer. 2019-03-01 - 131 citationsOutcome for adolescent and young adult patients with osteosarcoma: a report from the Children's Oncology Group.Katherine A. Janeway, Donald A. Barkauskas, Mark Krailo, Paul A. Meyers, Cindy L. Schwartz
Cancer. 2012-09-15
Grant Support
- A Phase I Trial Of G3139 Combined W/ Cytotoxic Chemotherapy In RelapsedNational Center For Research Resources2005
- Pediatric Oncology GroupNational Cancer Institute1992–2002
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: